173 related articles for article (PubMed ID: 22554872)
21. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
Davey J; Leal N; Freeman J
Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
[TBL] [Abstract][Full Text] [Related]
22. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
23. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
24. Opioids in oral fluid of Spanish drivers.
Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
[TBL] [Abstract][Full Text] [Related]
25. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
Logan BK; Mohr AL; Talpins SK
J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
[TBL] [Abstract][Full Text] [Related]
26. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
27. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Matzopoulos R; Lasarow A; Bowman B
Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
Buchan BJ; Walsh JM; Leaverton PE
J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
[TBL] [Abstract][Full Text] [Related]
29. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving.
Arroyo A; Sánchez M; Barberia E; Barbal M; Marrón MT; Mora A
Med Leg J; 2013; 81(Pt 3):135-43. PubMed ID: 24057314
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
Gjerde H; Normann PT; Christophersen AS; Mørland J
Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
[TBL] [Abstract][Full Text] [Related]
31. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
33. Roadside drug testing: comparison of two legal approaches in Belgium.
Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
35. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
[TBL] [Abstract][Full Text] [Related]
36. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
37. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS.
Cirimele V; Villain M; Mura P; Bernard M; Kintz P
Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544
[TBL] [Abstract][Full Text] [Related]
38. Applicability of an on-site test for its use in post-mortem blood.
Arroyo A; Sánchez M; Palahí M; Barbal M; Marrón MA; Mora A
Leg Med (Tokyo); 2011 Sep; 13(5):240-4. PubMed ID: 21821456
[TBL] [Abstract][Full Text] [Related]
39. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation.
Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
